Viewing Study NCT00996268


Ignite Creation Date: 2025-12-24 @ 5:31 PM
Ignite Modification Date: 2026-01-01 @ 7:46 PM
Study NCT ID: NCT00996268
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2009-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Single Dose Randomized, Parallel Group Study Followed by Single-blind Repeat Dosing, to Compare the Relative Bioavailability of GSK2212836.
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module